Next-Generation GLP-1 Analogues Drive New Opportunities in Obesity...

added blog Tanıtım

2026-06-08 20:37:56

Next-Generation GLP-1 Analogues Drive New Opportunities in Obesity and Cardiovascular Care

The global GLP-1 analogues market is experiencing unprecedented growth, driven by the increasing prevalence of type 2 diabetes and obesity, expanding therapeutic applications, and continuous innovation in drug formulations. According to industry estimates, the market was valued at US$ 51.6 billion in 2024 and is projected to reach US$ 211.8 billion by 2035, expanding at a robust CAGR of 13.7%...

0 Comments 0 Shares 20 Views 0 Reviews